Protocol: - BPC-157: 300-500 mcg/day subcutaneous near the affected joint - TB-500: 2-2.5 mg twice per week subcutaneous (abdomen) - Duration: 6-8 weeks Best for: Acute joint injuries, post-surgical recovery, chronic joint pain that has not responded to single peptides
Learn about collagen synthesis, skin repair mechanisms, anti-aging research, purity, and ORYN's pen delivery system.
(2008) described a significant increase in the CSF levels of the polyunsaturated fatty acid eicosapentanoic acid (EPA) in patients with PD and MSA
Besides, EpCAM overexpression is related to Wnt/-catenin pathway activation in cancers, which is a potential causal pathway for cytoplasmic and nuclear accumulation of -catenin, indicating proliferation and reduced apoptosis in cancer cells [141]
Guerra-Castellano et al., 2018